PUBLICATION

Zebrafish-based identification of the antiseizure nucleoside inosine from the marine diatom Skeletonema marinoi

Authors
Brillatz, T., Lauritano, C., Jacmin, M., Khamma, S., Marcourt, L., Righi, D., Romano, G., Esposito, F., Ianora, A., Queiroz, E.F., Wolfender, J.L., Crawford, A.D.
ID
ZDB-PUB-180426-3
Date
2018
Source
PLoS One   13: e0196195 (Journal)
Registered Authors
Crawford, Alexander
Keywords
none
MeSH Terms
  • Animals
  • Anticonvulsants/chemistry
  • Anticonvulsants/isolation & purification
  • Anticonvulsants/therapeutic use*
  • Chemical Fractionation
  • Diatoms/chemistry*
  • Disease Models, Animal
  • Inosine/chemistry
  • Inosine/isolation & purification
  • Inosine/therapeutic use*
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Pentylenetetrazole/adverse effects*
  • Seizures/chemically induced
  • Seizures/drug therapy*
  • Zebrafish
PubMed
29689077 Full text @ PLoS One
Abstract
With the goal of identifying neuroactive secondary metabolites from microalgae, a microscale in vivo zebrafish bioassay for antiseizure activity was used to evaluate bioactivities of the diatom Skeletonema marinoi, which was recently revealed as being a promising source of drug-like small molecules. A freeze-dried culture of S. marinoi was extracted by solvents with increasing polarities (hexane, dichloromethane, methanol and water) and these extracts were screened for anticonvulsant activity using a larval zebrafish epilepsy model with seizures induced by the GABAA antagonist pentylenetetrazole. The methanolic extract of S. marinoi exhibited significant anticonvulsant activity and was chosen for bioassay-guided fractionation, which associated the bioactivity with minor constituents. The key anticonvulsant constituent was identified as the nucleoside inosine, a well-known adenosine receptor agonist with previously reported antiseizure activities in mice and rat epilepsy models, but not reported to date as a bioactive constituent of microalgae. In addition, a UHPLC-HRMS metabolite profiling was used for dereplication of the other constituents of S. marinoi. Structures of the isolated compounds were elucidated by nuclear magnetic resonance and high-resolution spectrometry. These results highlight the potential of zebrafish-based screening and bioassay-guided fractionation to identify neuroactive marine natural products.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping